• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ets 1在毛细血管中表达,但在淋巴管中不表达。

Ets 1 is expressed in capillary blood vessels but not in lymphatics.

作者信息

Wernert Nicolas, Okuducu Ali-Fuat, Pepper Michael S

机构信息

Institute of Pathology, University of Bonn, PO Box 2120, 53011 Bonn, Germany.

出版信息

J Pathol. 2003 Aug;200(5):561-7. doi: 10.1002/path.1380.

DOI:10.1002/path.1380
PMID:12898591
Abstract

Little is known about the mechanisms that regulate lymphangiogenesis and, in particular, about regulation at the transcriptional level. To determine whether parallels exist in the mechanisms of angiogenesis and lymphangiogenesis, the expression of the Ets 1 transcription factor (which has previously been shown to be involved in angiogenesis) was examined in two transgenic mouse lines, namely RipVEGF-C mice (which develop lymphatic capillaries ectopically around islets of Langerhans) and Rip1Tag2 mice (which develop insulinomas that are not lymphangiogenic). Crossing the two lines results in double transgenic mice that develop lymphatics around insulinomas, which in turn promotes metastasis to regional lymph nodes. By immunohistochemistry, it was found that, in contrast to blood vessels, lymphatic vessels in wild-type and transgenic mice did not express Ets 1. Immunohistochemical staining for matrix metalloproteinase (MMP)-2 and MMP-9 as well as membrane type 1-MMP (MT1-MMP/MMP-14), all of which are encoded by known or potential Ets 1 target genes, showed the same cellular distribution as Ets 1. These findings suggest that the transcriptional regulatory mechanisms of lymphangiogenesis differ from those involved in angiogenesis. Furthermore, if proteases are involved in lymphangiogenesis, these observations suggest that they are different from those considered to be important for blood vessel formation.

摘要

关于调节淋巴管生成的机制,尤其是转录水平的调节,我们知之甚少。为了确定血管生成和淋巴管生成机制中是否存在相似之处,我们在两种转基因小鼠品系中检测了Ets 1转录因子(先前已证明其参与血管生成)的表达,即RipVEGF-C小鼠(在胰岛周围异位形成淋巴管)和Rip1Tag2小鼠(形成不发生淋巴管生成的胰岛素瘤)。将这两种品系杂交产生双转基因小鼠,其在胰岛素瘤周围形成淋巴管,进而促进向区域淋巴结转移。通过免疫组织化学发现,与血管不同,野生型和转基因小鼠的淋巴管不表达Ets 1。对基质金属蛋白酶(MMP)-2、MMP-9以及膜型1-MMP(MT1-MMP/MMP-14)进行免疫组织化学染色,所有这些均由已知或潜在的Ets 1靶基因编码,结果显示它们与Ets 1具有相同的细胞分布。这些发现表明,淋巴管生成的转录调控机制与血管生成的不同。此外,如果蛋白酶参与淋巴管生成,这些观察结果表明它们与那些被认为对血管形成很重要的蛋白酶不同。

相似文献

1
Ets 1 is expressed in capillary blood vessels but not in lymphatics.Ets 1在毛细血管中表达,但在淋巴管中不表达。
J Pathol. 2003 Aug;200(5):561-7. doi: 10.1002/path.1380.
2
Lymphatics and vascular channels; the differences behind similarity.淋巴管与血管通道:相似背后的差异
J Pathol. 2003 Aug;200(5):551-2. doi: 10.1002/path.1393.
3
Expression of the ets-1 proto-oncogene in human pancreatic carcinoma.ets-1原癌基因在人胰腺癌中的表达。
Mod Pathol. 1998 Feb;11(2):209-15.
4
Expression of Ets-1 transcription factor in relation to angiogenesis in the healing process of gastric ulcer.Ets-1转录因子表达与胃溃疡愈合过程中血管生成的关系
Biochem Biophys Res Commun. 1998 May 8;246(1):123-7. doi: 10.1006/bbrc.1998.8585.
5
The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer.在浸润前乳腺癌的基质中,Ets-1转录因子与基质金属蛋白酶1(MMP 1)和基质金属蛋白酶9(MMP 9)一起上调。
J Pathol. 2001 May;194(1):43-50. doi: 10.1002/path.844.
6
RETRACTED: Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2.撤回:前列腺素E2通过Ets-1依赖性诱导基质金属蛋白酶-2增强胰腺癌的侵袭性。
Cancer Res. 2004 Oct 15;64(20):7439-46. doi: 10.1158/0008-5472.CAN-04-1177.
7
Role of transcription factors in angiogenesis: Ets-1 promotes angiogenesis as well as endothelial apoptosis.转录因子在血管生成中的作用:Ets-1促进血管生成以及内皮细胞凋亡。
Ann N Y Acad Sci. 2001 Dec;947:117-23.
8
Expression of ets-1 transcription factor in human head and neck squamous cell carcinoma and effect of histamine on metastatic potential of invasive tumor through the regulation of expression of ets-1 and matrix metalloproteinase-3.ets-1转录因子在人头颈鳞状细胞癌中的表达以及组胺通过调控ets-1和基质金属蛋白酶-3的表达对侵袭性肿瘤转移潜能的影响。
Head Neck. 2005 Jul;27(7):585-96. doi: 10.1002/hed.20188.
9
The regulation of COUP-TFII gene expression by Ets-1 is enhanced by the steroid receptor co-activators.类固醇受体共激活因子增强了Ets-1对COUP-TFII基因表达的调控。
Mech Ageing Dev. 2004 Oct-Nov;125(10-11):719-32. doi: 10.1016/j.mad.2004.03.009.
10
Ets-2 overexpression contributes to progression of pancreatic adenocarcinoma.
Oncol Rep. 2002 Jul-Aug;9(4):853-7.

引用本文的文献

1
ETS transcription factors in embryonic vascular development.胚胎血管发育中的ETS转录因子。
Angiogenesis. 2016 Jul;19(3):275-85. doi: 10.1007/s10456-016-9511-z. Epub 2016 Apr 28.
2
Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic function.细胞外基质与淋巴管的相互作用:对淋巴管生成和淋巴管功能的影响。
Matrix Biol. 2010 Oct;29(8):645-56. doi: 10.1016/j.matbio.2010.08.001. Epub 2010 Aug 18.
3
Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers.
DNA结合抑制因子(ID)-1蛋白作为血管生成介质在子宫颈癌肿瘤进展中的表达
Br J Cancer. 2008 Nov 18;99(10):1557-63. doi: 10.1038/sj.bjc.6604722. Epub 2008 Oct 28.
4
Epigenetics of prostate cancer: beyond DNA methylation.前列腺癌的表观遗传学:超越DNA甲基化
J Cell Mol Med. 2006 Jan-Mar;10(1):100-25. doi: 10.1111/j.1582-4934.2006.tb00293.x.
5
Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma.ID1蛋白的高表达与恶性黑色素瘤患者生存率降低、ephrin-A1/EPHA2表达增加以及血小板反应蛋白-1减少相关。
Br J Cancer. 2005 Oct 17;93(8):933-8. doi: 10.1038/sj.bjc.6602792.
6
[Lymph vascularity and lymph node metastases on PET and PET-CT: immunohistological and clinical observations].
Chirurg. 2005 May;76(5):493-500. doi: 10.1007/s00104-005-1015-0.
7
Lack of lymphangiogenesis during breast carcinogenesis.乳腺癌发生过程中淋巴管生成的缺失。
J Clin Pathol. 2004 Jul;57(7):746-51. doi: 10.1136/jcp.2003.014480.